Tariff on pharma imports could hurt the US as well. (Image: NDTV Profit) Show Quick Read Summary is AI Generated. Newsroom Reviewed

US President Donald Trump has once again stirred global markets by announcing a steep 100% tariff on import of branded and patented pharmaceutical drugs, effective Oct. 1.

"Starting October 1st, 2025, we will be imposing a 100% tariff on any branded or patented pharmaceutical product, unless a company is building their pharmaceutical manufacturing plant in America," the US President said in a social media post on Truth Social.

The move is likely to have a major impact on the Indian drugmakers, with Emkay Global's Manish Sonthalia pegging an impact of $10 billion.

Brokerages, too, have pointed out potential impact of US tariffs on Indian companies, esp

See Full Page